Results
86
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
86 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.60 | -0.6% | 32.5% | SEK 433.8m | SEK 2.20 | PS4.7x | E90.4% | n/a | Tech | ||
CALTX | SEK 205.60 | 0% | 137.0% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 231.50 | 2.2% | 131.5% | SEK 19.9b | SEK 265.00 | PE120.4x | E43.8% | n/a | Software | ||
CTT | SEK 313.00 | -3.1% | 44.2% | SEK 3.9b | n/a | PE38.4x | E21.6% | 1.7% | Capital Goods | ||
YIELD | SEK 2.56 | 2.8% | -65.7% | SEK 146.7m | SEK 9.00 | PB1.7x | E103.4% | n/a | Diversified Financials | ||
SILEON | SEK 0.58 | 3.6% | -87.1% | SEK 29.4m | n/a | PB1.9x | E109.3% | n/a | Software | ||
BIOA B | SEK 220.80 | -3.5% | -25.7% | SEK 19.5b | SEK 368.00 | PS77.3x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 0.51 | -2.7% | -32.1% | SEK 18.8m | n/a | PB0.3x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.48 | -9.8% | -63.1% | SEK 208.5m | SEK 7.90 | PS28.6x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.54 | -0.8% | -26.6% | SEK 274.7m | SEK 3.65 | PS2.8x | E104.9% | n/a | Tech | ||
ORGC | SEK 3.78 | -1.6% | -20.4% | SEK 370.9m | SEK 3.00 | PS2.6x | E102.0% | n/a | Materials | ||
CRAD B | SEK 43.05 | -1.3% | 57.1% | SEK 1.4b | SEK 56.00 | PE30x | E30.4% | n/a | Healthcare | ||
ORT B | SEK 8.68 | 3.6% | 19.6% | SEK 321.9m | SEK 18.00 | PS5.1x | E62.8% | n/a | Healthcare | ||
MIDS | SEK 1.40 | -24.0% | -37.5% | SEK 293.6m | SEK 2.80 | PS4.6x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 7.15 | -0.7% | -35.3% | SEK 211.0m | SEK 16.50 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.38 | -13.4% | -41.2% | SEK 49.4m | SEK 1.00 | PB1.7x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
EGTX | SEK 4.49 | -3.9% | 9.6% | SEK 1.3b | SEK 13.30 | PS20.9x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
FNOX | SEK 63.44 | -0.8% | 3.0% | SEK 38.7b | SEK 73.78 | PE63.1x | E21.1% | 0.3% | Software | ||
QLIRO | SEK 26.25 | 14.1% | 2.5% | SEK 502.6m | SEK 21.00 | PE78.5x | E71.9% | n/a | Diversified Financials | ||
NIUTEC | SEK 7.04 | 4.5% | -41.2% | SEK 139.9m | SEK 9.50 | PB1.7x | E94.1% | n/a | Capital Goods | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
NAVIGO STAM | SEK 3.80 | -6.6% | n/a | SEK 491.3m | SEK 6.20 | PE614.6x | E77.4% | n/a | Diversified Financials | ||
ASAI | SEK 0.53 | -5.4% | -52.5% | SEK 195.9m | n/a | PS2.3x | E66.6% | n/a | Software | ||
STIL | SEK 208.00 | -4.1% | 90.8% | SEK 1.9b | SEK 231.50 | PE52.5x | E36.0% | 0% | Healthcare |